Page last updated: 2024-09-04

yh 439 and 2,3,7,8-tetrachlorodibenzodioxine

yh 439 has been researched along with 2,3,7,8-tetrachlorodibenzodioxine in 1 studies

Compound Research Comparison

Studies
(yh 439)
Trials
(yh 439)
Recent Studies (post-2010)
(yh 439)
Studies
(2,3,7,8-tetrachlorodibenzodioxine)
Trials
(2,3,7,8-tetrachlorodibenzodioxine)
Recent Studies (post-2010) (2,3,7,8-tetrachlorodibenzodioxine)
21021506

Protein Interaction Comparison

ProteinTaxonomyyh 439 (IC50)2,3,7,8-tetrachlorodibenzodioxine (IC50)
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.0027

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Antonchick, AP; Brause, A; Dötsch, L; Flegel, A; Flegel, J; Hoffmann, JE; Janning, P; Jia, ZJ; Krzyzanowski, A; Lian, Y; Metz, M; Moura-Alves, P; Rastinejad, F; Reich, A; Schade, D; Scheel, R; Schneidewind, T; Schulte, B; Shaaban, S; Sievers, S; Stender, ID; Strohmann, C; Waldmann, H; Wesseler, F; Xue, G; Zhang, M; Ziegler, S1

Other Studies

1 other study(ies) available for yh 439 and 2,3,7,8-tetrachlorodibenzodioxine

ArticleYear
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation.
    Journal of medicinal chemistry, 2022, 12-22, Volume: 65, Issue:24

    Topics: Cell Differentiation; Hedgehog Proteins; Osteoblasts; Receptors, Aryl Hydrocarbon; Signal Transduction

2022